Search by Drug Name or NDC
NDC 65162-0670-10 Acebutolol Hydrochloride 400 mg/1 Details
Acebutolol Hydrochloride 400 mg/1
Acebutolol Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is ACEBUTOLOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Acebutolol is used to treat high blood pressure. Acebutolol also is used to treat an irregular heartbeat. Acebutolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 65162-0670-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Acebutolol
Product Information
| NDC | 65162-0670 |
|---|---|
| Product ID | 65162-670_1d5acb47-1406-4d03-b1cb-b5c0b6a464b8 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Acebutolol Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acebutolol Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/1 |
| Substance Name | ACEBUTOLOL HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075047 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0670-10 (65162067010)
| NDC Package Code | 65162-670-10 |
|---|---|
| Billing NDC | 65162067010 |
| Package | 100 CAPSULE in 1 BOTTLE (65162-670-10) |
| Marketing Start Date | 2009-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |